Results for cellular protein translation from English to Estonian

protein
valk

cellular/bwa
mobiilside / traadita lairibaühendus

cellular telephones
mobiiltelefonid

new cellular connection
uus mobiiliühendus@ info: status interface (% 2) status notification title when a connection (% 1) is activating

somatropin promotes cellular protein synthesis and nitrogen retention.
somatropiin soodustab tsellulaarsete valkude sünteesi ja lämmastiku retentsiooni.

additionally, it promotes cellular protein synthesis and nitrogen retention.
peale selle soodustab see tsellulaarsete valkude sünteesi ja lämmastiku retentsiooni.

fcd: floating car / cellular data
fcd: floating car / cellular data (sõiduki muutuvad andmed)

upon internalization by cells, it is localized within cellular lysosomes, thereby limiting distribution of the protein.
pärast rakku sisenemist lokaliseerub see raku lüsosoomides, piirates sellega valgu jaotumist.

digital cellular telecommunications system (phase 2);
digitaalne mobiilsidesüsteem (2. faas);

- soy protein revitalizing that increase oxygenation and cellular metabolism ;
- sojavalk elustav et hapnikuga ning rakkude ainevahetust ;

the cellular sequela of inhibition of topoisomerase-i by topotecan is the induction of protein- associated dna single-strand breaks.
topotekaani poolt topoisomeraas-i pärssimise rakusiseseks tagajärjeks on valguliselt seotud dna ühekeermeliste katkestuste teke.

plasma protein binding is approximately 96 %, with negligible binding to cellular blood components.
plasmavalkudega seondub umbes 96 %, vere rakuliste komponentidega seondumine on ebaoluline.

plasma protein binding of irbesartan is approximately 96%, with negligible binding to cellular blood components.
irbesartaan seondub plasmavalkudega umbes 96% ulatuses; vererakkudega seondumine on ebaoluline.

imatinib is a protein kinase inhibitor which potently inhibits the bcr-abl tyrosine kinase at the in vitro, cellular and in vivo levels.
imatiniib on proteiini kinaasi inhibiitor, mis pärsib tugevalt bcr-abl türosiinkinaasi in vitro, rakulisel ja in vivo tasemel.

imatinib is a protein-tyrosine kinase inhibitor which potently inhibits the bcr-abl tyrosine kinase at the in vitro, cellular and in vivo levels.
imatiniib on proteiintürosiinkinaasi inhibiitor, mis pärsib tugevalt bcr-abl türosiinkinaasi in vitro, rakulisel ja in vivo tasemel.

whole, broken or crushed bones, meat peptones, animal gelatin, meat powder, pork-rind powder, blood plasma, dried blood, dried blood plasma, cellular proteins, bone extracts and similar products;
terved, purustatud või peenestatud kondid, lihapeptoon, loomne želatiin, lihapulber, kamarapulber, vereplasma, kuivatatud veri, kuivatatud vereplasma, rakuproteiinid, kondiekstraktid ja samalaadsed tooted;